Treatment of Papillary Thyroid Carcinoma with Tumor ≤1 cm, Limited to the Thyroid (cT1aN0M0)
This protocol addresses a specific low-risk presentation of papillary thyroid cancer: a primary tumor no larger than 1 cm that is confined to the thyroid, with no involvement of regional cervical lymph nodes and no distant spread.
Clinical scenario: Papillary thyroid carcinoma with tumor ≤1 cm limited to the thyroid (cT1a), no regional cervical lymph node metastasis (cN0), and no distant metastasis (cM0).
For appropriately selected patients with this presentation, active surveillance — ongoing observation with serial neck ultrasound — is recognised as an appropriate management option. It is not the only path. The complete protocol defines which approach applies and under what conditions.
Management approach: Structured options span observation-based and procedural strategies. The full protocol specifies the selection criteria and the conditions under which each applies — access it below.
References
DOI: 10.1177/10507256251363120
- Active surveillance may be offered as an appropriate management option for some patients with cT1aN0M0 PTCs.
- Ultrasound-guided percutaneous ablation may be considered as an alternative to active surveillance or resection for cT1aN0M0 PTC in selected patients.
- When resection is performed for patients with thyroid cancer ≤2 cm without gross extra-thyroidal extension (cT1) and without metastases (cN0M0), the initial surgical procedure should be a thyroid lobectomy unless there are bilateral cancers or other indications to remove the contralateral lobe.
View source ↗